INNOVATIVE THINKING
RIGOROUS APPROACHES
REAL WORLD IMPACT

 

Ms. Christine Gill

Ms. Christine Gill, an Epidemiologist and Research Associate at IMPAQ International, has more than eight years of experience managing projects in pharmaceutical health services research. During this time, Ms. Gill has leveraged her training in Epidemiology and developed expertise in designing and implementing retrospective, observational studies. 

Expertise

In addition to her experience with project management and statistical analysis, Ms. Gill has extensive knowledge of multiple databases used in health services research. This includes the United States Renal Data Systems (USRDS), Chronic Condition Warehouse (CCW) Medicare data linked to the Part D files and the Long Term Care Minimum Data Set (MDS), Maryland Medicaid, Surveillance, Epidemiology and End Results (SEER) linked with Medicare data, General Electric Centricity™ electronic medical records, and Philips eRI ICU electronic medical records. Ms. Gill has developed technical specifications for analytic file development using knowledge of the databases and has operationalized clinical metrics using First Databank MedKnowledge and Optum Coding diagnosis and procedure code dictionaries. Additionally, she has been manipulating large secondary data sources in SAS for more than 9 years using data step, procedures, and macros. 

Clients

Prior to joining IMPAQ, Ms. Gill worked in an academic research environment, where the majority of her clients were academic researchers.

Prior Experience

Prior to joining IMPAQ, Ms. Franey worked at Pharmaceutical Research Computing, a center within University of Maryland School of Pharmacy in the Pharmaceutical Health Services Research department. While there, Ms. Franey worked to manage projects and design observational studies, mainly utilizing secondary data sources, including those based on administrative claims and electronic health records. Ms. Franey worked extensively in the acquisition, cleaning, and preparation of these data source to produce research-ready, analytic files. The data sets Ms. Franey is expert in manipulating and analyzing include: United States Renal Data Systems (USRDS), Chronic Condition Warehouse (CCW) Medicare data linked to the Part D files and the Long Term Care Minimum Data Set (MDS), Maryland Medicaid, Surveillance, Epidemiology and End Results (SEER) linked with Medicare data, General Electric Centricity™ electronic medical records, and Philips eRI ICU electronic medical records.

Education

Ms. Franey is a Ph.D. candidate at the University of Maryland School of Medicine. She also earned her M.P.H. in Epidemiology from the University of Michigan, Ann Arbor and her B.S. in Mathematics and Chemistry from Simmons College.         

IMPAQ Papers and Presentations

Gill, C. (2017, May). Environmental Scan of Medication Therapy Management Monitoring Measures. Presentation at the Pharmacy Quality Alliance Annual Meeting, Baltimore, MD.

Stolker J.M., Badawi O., Spertus J.A., Nasir A., Kennedy K.F., Harris I.H., Franey C.S., Hsu V.D., Ripple G.R., Howell G.H., Lem V.M., Chan P.S. (2015). Intensive care units with low versus high volume of myocardial infarction: Clinical outcomes, resource utilization, and quality metrics. J Am Heart Assoc.

Harris I., Marsteller J., Kiptanui Z., Pedersen S., Perlmutter D., Franey C., Hsu Y., Xu L., Tegbe M., Emery D. (2015). Evaluation of the Maryland Multi-Payor Patient Centered Medical Home Program: Final Report. Maryland Health Care Commission.

Dutcher S.K., Rattinger G.B., Langenberg P., Chhabra P.T., Liu X., Rosenberg P.B., Leoutsakos J.M., Simoni-Wastila L., Walker L.D., Franey C.S., Zuckerman I.H. (2014). Effect of medications on physical function and cognition in nursing home residents with dementia. J Am Geriatr Soc, 62(6),1046-55.

Lilly C.M., Liu X., Badawi O., Franey C.S., Zuckerman I.H. (2014). Thrombosis Prophylaxis and Mortality Risk among Critically Ill Adults. Chest, 13-2160.

Simoni-Wastila L., Wei Y.J., Luong M., Franey C., Huang T.Y., Rattinger G.B., Zuckerman I.H., Brandt N., Lucas J.A. (2014). Quality of psychopharmacological medication use in nursing home residents. Res Social Adm Pharm, 10(3), 494- 507.

Waite M.D., Fuhrman S.A., Badawi O., Zukerman I.H., Franey C.S. (2013). Intensive care unit-acquired hypernatremia is an independent predictor of increased mortality and length of stay. J Crit Care, 28(4), 405-12.

Mullins, C.D., Jain, R., Weir, M.R., Franey, C.S., Shih, Y.T., Pradel, F.G., Bikov, K., Bartlett S.T. (2013). Benefits Improvement and Protection Act’s Impact on Transplantation Rates Among Elderly MEDICARE Beneficiaries with End-Stage Renal Disease. Transplantation, 95(3), 463-9.

Rattinger G.B., Burcu M., Dutcher S.K., Chhabra P.T., Rosenberg P.B., Simoni-Wastila L., Franey C.S., Walker L.D., Zuckerman I.H. (2013). Pharmacotherapeutic Management of Dementia across Care Settings. Journal of American Geriatric Society.

McPhee L.C., Badawi O., Fraser G.L., Lerwick P.A., Riker R.R., Zuckerman I.H., Franey C., Seder D.B. (2013). Single-dose etomidate is not associated with increased mortality in ICU patients with sepsis: Analysis of a large electronic ICU database. Critical Care Medicine, 41(3), 774-83.

Rattinger G.B., Dutcher S.K., Chhabra P.T., Franey C.S., Simoni-Wastila L, Gottlieb S.S., Stuart B., Zuckerman I.H. (2012). The effect of dementia on medication use and adherence among Medicare beneficiaries with chronic heart failure. The American Journal of Geriatric Pharmacotherapy, 10(1), 69-80.